Percutaneous coronary intervention in patients with end-stage renal disease

Kidney and Blood Pressure Research

Volumn 28, Issue 5-6, 2006, Pages 275-279

  Bocksch, Wolfgang ^a   Fateh Moghadam, Suzanne ^a   Mueller, Eda ^a   Huehns, Sonja ^a   Waigand, Juergen ^a   Dietz, Rainer ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Coronary artery disease; End stage renal disease; Myocardial infarction; Percutaneous coronary intervention

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE; TIROFIBAN;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DEVELOPED COUNTRY; DIAGNOSTIC TEST; DRUG ELUTING STENT; EPIDEMIOLOGICAL DATA; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; INCIDENCE; INTERMETHOD COMPARISON; KIDNEY FAILURE; MEDICAL EDUCATION; NON INVASIVE MEASUREMENT; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; RESTENOSIS; ST SEGMENT ELEVATION; THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; CORONARY DISEASE; CORONARY VESSELS; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL REVASCULARIZATION;

EID: 33644969320     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090181     Document Type: Article

References (27)

1. Renal Data System: USRDS 2002 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002.
2. Renal Data System: USRDS 2000 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2000.
3. Lippert J, Ritz E, Schwarzbeck A, et al: The rising tide of end stage renal failure from diabetic nehropathy type II: an epidemiologic analysis. Nephrol Dial Transplant 1995;10:462-467.
4. Herzog CA, Ma JZ, Collins AJ: Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998;339:799-805.
5. Herzog CA: Noninvasive diagnosis of CAD in patients with end-stage renal disease; in Marwick TH (ed): Cardiac Stress Testing and Imaging. London, Churchill-Livingstone, 1996, pp 203-222.
6. Herzog CA, Marwick TH, Pheley AM, et al: Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 1999;33:1080-1090.
7. Nagel E, Lehmkuhl HB, Bocksch W, et al: Non-invasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999;99:763-770.
8. Goodman WG, Goldin J, Kuizon BD, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483.
9. Manske CL, Wang Y, Rector T, et al: Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992;340:998-1002.
10. Liu JY, Birkmeyer NJ, Sanders JH, et al: Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 2000;102: 2973-2977.
11. Herzog CA, Ma JZ, Collins AJ: Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures. Circulation 2004;109:2866-2871.
12. Kahn JK, Rutherford BO, McConahay DR, et al: Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990;119:484-489.
13. Azar JJ, Prpic R, Ho KK, et al: Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000;86:485-489.
14. Moses J, Leon MB, Piopma JJ, et al: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
15. Lemos PA, Arampatzis CA, Hoye A, et al: Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus eluting stents or bare metal stents. Am J Cardiol 2005;95:167-172.
16. Fitzgerald P, Ports TA, Yock PG: Contribution of localized calcium deposits to dissection after angioplasty: an observational study using intravascular ultrasound. Circulation 1992;86:64-70.
17. De Gregorio J, Colombo A: Treatment strategies for long and calcified lesions. J Intervent Cardiol 1998;11:557-664.
18. Herzog CA, Ma JZ, Collins AJ: Long-term survival of dialysis patients receiving thrombolytic therapy for acute myocardial infarction in the US (abstract). Circulation 1999;100(suppl 1):I-304.
19. Herzog CA, Ma JZ, Collins AJ: Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kidney Dis 2000;36:145-152.
20. Silber S, Albertsson P, Aviles FF, et al: Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-847.
21. Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003;361:13-20.
22. Frilling B, Zahn R, Fraiture B, et al: Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximab. Am J Cardiol 2002;89:450-452.
23. Yusuf S, Zhao F, Mehta SR, et al: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
24. Cannon CP, Weintraub WS, Demopoulos LA, et al, for the TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy) - Thrombolysis in Myocardial Infarction 18 Investigators: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887.
25. Januzzi JL, Snapinn SM, DiBattiste PM, et al: Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency. Circulation 2002;105:2361-2366.
26. Freeman RV, Mehta RH, Al Badr W, et al: Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol 2003;41:718-724.
27. Jeremias A, Bhatt DL, Chew DP, et al: Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency. Am J Cardiol 2002;89:1209-1211.